Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$12.5 - $52.0 $87,850 - $365,456
-7,028 Reduced 21.39%
25,824 $9,000
Q4 2021

Feb 14, 2022

BUY
$46.5 - $104.0 $190,231 - $425,464
4,091 Added 14.22%
32,852 $31,000
Q3 2021

Nov 15, 2021

SELL
$80.5 - $175.0 $130,329 - $283,325
-1,619 Reduced 5.33%
28,761 $60,000
Q2 2021

Aug 16, 2021

SELL
$95.0 - $156.5 $827,925 - $1.36 Million
-8,715 Reduced 22.29%
30,380 $72,000
Q1 2021

May 17, 2021

BUY
$131.5 - $245.0 $5.14 Million - $9.58 Million
39,095 New
39,095 $120,000

About Enveric Biosciences, Inc.


  • Ticker ENVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,078,270
  • Market Cap $665K
  • Description
  • Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...
More about ENVB
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.